Fenofibrate immediate release - SCOLR
Alternative Names: CDT fenofibrate - SCOLRLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator SCOLR Pharma
- Class Antihyperlipidaemics; Benzophenones; Butyric acids; Fibric acid derivatives; Propionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Hypercholesterolaemia
Most Recent Events
- 01 Mar 2013 SCOLR Pharma has ceased its business operations
- 01 Mar 2013 Discontinued - Phase-I for Hypercholesterolaemia in Canada (PO)
- 01 Mar 2013 Discontinued - Preclinical for Hypercholesterolaemia in USA (PO)